Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells

BACKGROUND: Our previous studies showed that the non-psychoactive cannabinoid, cannabidiol (CBD), ameliorates the clinical symptoms in mouse myelin oligodendrocyte glycoprotein (MOG)35-55-induced experimental autoimmune encephalomyelitis model of multiple sclerosis (MS) as well as decreases the memo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozela, Ewa, Juknat, Ana, Gao, Fuying, Kaushansky, Nathali, Coppola, Giovanni, Vogel, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891926/
https://www.ncbi.nlm.nih.gov/pubmed/27256343
http://dx.doi.org/10.1186/s12974-016-0603-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891926/
https://www.ncbi.nlm.nih.gov/pubmed/27256343
http://dx.doi.org/10.1186/s12974-016-0603-x

Ejemplares similares